Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added related topics: Multiple myeloma and a MedlinePlus Genetics link in the Related Topics section.
    Difference
    0.2%
    Check dated 2026-01-01T03:45:57.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now displays a new footer/version label 'Revision: v3.3.3' and removes ancillary footer links like HHS Vulnerability Disclosure and MedlinePlus Genetics; these changes affect navigation and metadata but do not alter study details or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-17T20:25:15.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Publication section now includes a note that items are automatically filled from PubMed and may not be about the study. The revision version has been updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:52:33.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The government funding/operating-status notice at the bottom of the page was removed, removing guidance about potential site-wide delays and where to check for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T08:38:36.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The two screenshots show only minor layout and formatting adjustments to the study details page, with no changes to core study content (title, identifiers, eligibility criteria, design, or outcome measures). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:13:06.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Multiple myeloma, expanding the core content to include genetics-related information on this disease. No deletions. If this is a medical information page, expect broader coverage on genetics and multiple myeloma.
    Difference
    0.2%
    Check dated 2025-10-21T01:31:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.